George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Been dummy buying for a few days, .68 offer every time. Now they drop it a tad, think I'll keep watching.
We all know what is causing the hiatus, until that's resolved I guess most will sit on their hands
Quite a few small £50 buys over the last few days ,Can’t see the point of buying in such small lots , commission must make it unviable as a trading strategy . !
0.51 to sell and 0.676 to buy. Crazy spread.
Political risk? Now I am confused! !
We all know that By-Health bought the Australian probiotics firm Life-Space group and although i am not suggesting there is a connection it reminded me of this Chinese patent for a "composition with intestinal and cardiovascular regulating function" that includes galactooligosaccharide and water-soluble tomato concentrate as raw materials.
Galactooligosaccharide is a type of Prebiotic.
https://patentscope.wipo.int/search/en/detail.jsf?docId=CN228767168&_cid=P10-KGG6Q7-95208-1
Not seen this combo before but DSM now seem to be offering a tablet with Probiotics and Fruitflow®
https://www.dsm.com/content/dam/dsm/human-nutrition/pdfs/HNH_Pre-Probiotics_Product_Brochure.pdf
Lack of logic. From 11 years ago until now, Fruitflow has progressed hugely. My opinion is that there is some POLITICAL risk, but that By Health have invested heavily to make a commercial splash one SAMR hurdle is jumped. The speculation in 09 had no substance, it was based on rumour. Today, there are numerous RNS confirmations of what is happening.
So all those people who purchased a month ago@0 90/0.80 or higher are gamblers? If China does not materialise :What is the future of PXS?
It's the " We have to maintain a going concern basis to comply with market rules. Stock in gradually larger quantities must be kept available for the retail part, patents and IP, contacts with past, present, and future to provide professional support and information to support a growing list of marketed Fruitflow brands. Liaison with all of the key people who efectively are Fruitflow, all must be maintained"
The alternative, the PumpColb solution, would be unthinkable to any rational investor. Those that threw in their cash blind before any progress had been made are the least reliable commentators. Pure gamblers.
Let's get financing done,Do you mean Dear shareholders we haven't made a profit in 11years and we need our wages paid?Is this the financing you describe?
The SAMR application is by far the biggest prospect for Fruitflow. Whilst DSM have had limited success, getting modest sized brands, and sub divisions of international companies, on board, BY Health are in quite a different league, with their own labs and the wherewithal to promote a range of Fruitflow focussed products.
Progress delayed by Covid, for sure, but that nasty illness has also created a whole new sales opportunity.
To steal a slogan, let's Get Financing Done!
That would be great but as you said it will happen when it happens , the trouble with giving the market an update is that the traders will pile in, and we could have an EFSA spike again , I think the bod will avoid that at any cost .
We could really be doing with a proper update on blue cap but can't see us getting one anytime soon.
Well I might be wrong but the arrows on the graphic does sort of indicate the sequence of events
The way I see it is...
If the whole process takes 2-3 years and By-Health did make there first submission in Feb 2019 then we could, in theory, be as little as 4 months away.
This time would be less, if as you say, the first 2 phases are completed before submission.
That link didn’t work , it’s registration procedure graphic
Gixer if you look at this graphic ,https://www.cekindo.vn/wp-content/uploads/2020/05/fig8.jpg. There are 2 phases before submission , if you take it that the whole process takes 2-3 years then surely these phases must take some considerable time to get to submission . Imo
Hi sphinx, could you explain why you think the submission process is half way through. I am not seeing the connection. Thanks.
We might be closer than we think , From 2018 interims , “· The six studies outlined are being conducted at BY-HEALTH's sole expense, a substantial investment in the Fruitflow® based products which BY-HEALTH plans to launch in China. Studies conducted in China are needed to obtain 'blue cap' health claim status for dietary supplements, as required by the Chinese State Administration for Market Regulation (SAMR), with BY-HEALTH intending to make its first submission to the SAMR for Fruitflow® in February 2019.” Looking at the information posted earlier the “ Submission “ is half way through the process , just a thought
Just to add, out of the 27 function claims that have been predefined in China there is some evidence that By-Health is targeting at least 2 of these so far for Fruitflow.
1. Aiding blood pressure reduction
2. Aiding blood lipids reduction
Good, easy to understand information on the approval procedure. thanks.
Also a good reminder of the "huge potential" of the Chinese market.
Keep the great work up. Nice to have positive and honest posters here. I am here to the end game. I am sure it will be a happy ending but you are never sure with Aim shares
If you read the document ,under registration procedures it requires a sample of the product Labeling , so you can only assume the by health products must be ready to go .!
Gixer it looks like 544 health food products already have Samr approval , which means some must take less than 2 years . https://www.cekindo.vn/blog/health-food-china-market-regulatory
Unlike yourself I am a bit more optimistic. We know that Blue Cap can take as little as 2 years and that could mean anytime from this coming February although I would expect a slight delay at SAMR due to Covid-19 . Its unlikely we will see any revenue from by-health this financial year that ends 31st of March but it could come quicker than you think.
Yes there could be a spike in the sp when Blue Cap is announced and some holders will use this to get out but having been here since 2009 I am happy to wait and see what value by-health will bring.
What good has research done? I have no idea but strangely i enjoy spending a few minutes in the morning ferreting around for info and products.